Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Tailor-Made Pharmaceuticals As Basis for Novel Antidepressants

December 2, 2014 12:42 pm | by Max Planck Institute | News | Comments

Scientists at the Max Planck Institute of Psychiatry in Munich have now developed the first potent and highly selective inhibitor for stress-related psychiatric disorders. Read more...             


Baxter Submits Application for Hemophilia A Treatment

December 2, 2014 12:32 pm | News | Comments

Baxter announced that it has submitted an application for FDA approval of a treatment for hemophilia A. Read more...                        


Vaccines May Make War on Cancer Personal

December 2, 2014 12:18 pm | by Michael C. Purdy, Washington University in St. Louis | News | Comments

Physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. Read more...                    


Antacids Linked to Better Survival in Head and Neck Cancer

December 2, 2014 12:03 pm | by University of Michigan | News | Comments

Patients with head and neck cancer who used antacid medicines to control acid reflux had better overall survival. Read more...                       


Hackers Target Email At Pharma and Healthcare Companies for Stock Info

December 2, 2014 11:55 am | News | Comments

The team has carried out attacks against nearly 100 publicly traded companies or their advisory firms in possible attempts to play the stock market. Read more...                


Predicting Alzheimer’s Disease With Blood Tests: Early Detection, Ethical Concerns

December 2, 2014 9:52 am | by Stephanie Guzowski, Editor | Articles | Comments

If you could take a blood test that could detect — with nearly 100% accuracy — whether you were genetically destined to get Alzheimer’s disease, would you take that test? Read more...


Bayer Receives Canada Approval for Vision Drug

December 2, 2014 9:49 am | News | Comments

Bayer Inc. announced that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). Read more...                             


New Molecules to Burst Malaria's Bubble

December 2, 2014 9:36 am | by Australian National University | News | Comments

Scientists have released details of a raft of new chemicals with potent anti-malarial properties which could open the way to new drugs to fight the disease. Read more...                                 


Stressed-Out Cancers May Provide Drug Target

December 2, 2014 9:30 am | by University of Adelaide | News | Comments

Research at the University of Adelaide has discovered cancer cells may be particularly susceptible to metabolic stress - opening the way for new targeted therapy that won't harm normal cells. Read more...                                 


Otsuka to Buy U.S. Drugmaker Avanir for $3.5B

December 2, 2014 9:22 am | News | Comments

Otsuka Pharmaceutical will spend $3.5 billion in cash to buy Avanir Pharmaceuticals in a deal that expands the Japanese drugmaker's portfolio of neurologic disease treatments. Read more...                         


Roche Acquires Ariosa, Enters NIPT Market

December 2, 2014 9:19 am | News | Comments

Roche announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA. Ariosa is a molecular diagnostics testing service provider that provides a highly targeted and accurate non-invasive prenatal testing (NIPT) service through their CLIA laboratory using cell-free DNA (cfDNA) technology. Read more...


Why Bowel Cancer Sometimes Outsmarts Treatment

December 1, 2014 1:32 pm | by Cancer Research UK | News | Comments

A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published in Nature Medicine. Cancer Research UK scientists have discovered that bowel cancer may not be restricted to starting its journey in the stem cells in the lining of the intestines as previously thought. Read more...


Breast Cancer Vaccine Shows Promise in Small Clinical Trial

December 1, 2014 1:02 pm | by Julia Evangelou Strait, Washington University | News | Comments

A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression. The study appears in Clinical Cancer Research. Read more...


HIV Drug Blocks Bone Metastases in Prostate Cancer

December 1, 2014 12:55 pm | by Thomas Jefferson University | News | Comments

Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. In a study published online in the journal Cancer Research, researchers show that the receptor CCR5 best known for its role in HIV therapy, may also be involved in driving the spread of prostate cancer to the bone. Read more...


Imaging Shows Brain Connection Breakdown in Early Alzheimer’s

December 1, 2014 12:45 pm | News | Comments

Changes in brain connections visible on MRI could represent an imaging biomarker of Alzheimer's disease, according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA). Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.